{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T03:16:55Z","timestamp":1783135015358,"version":"3.54.6"},"reference-count":140,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100008253","name":"Shaoxing University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008253","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.ejpb.2026.115120","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T23:36:05Z","timestamp":1779492965000},"page":"115120","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Hydrogels-based nasal sprays for nose-to-brain delivery: Formulation strategies, composite systems, and performance optimization"],"prefix":"10.1016","volume":"225","author":[{"given":"Xinshuang","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenna","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7740-3666","authenticated-orcid":false,"given":"Kewu","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2026.115120_b0005","first-page":"1","article-title":"Neurological disorders and challenges in their Theranostics, Theranostic applications of nanotechnology in neurological disorders","author":"Kumar","year":"2024","journal-title":"Singapore: Springer Nature Singapore"},{"issue":"1","key":"10.1016\/j.ejpb.2026.115120_b0010","article-title":"Drug delivery systems, CNS protection, and the blood brain barrier","volume":"2014","author":"Upadhyay","year":"2014","journal-title":"BioMed Research International"},{"key":"10.1016\/j.ejpb.2026.115120_b0015","doi-asserted-by":"crossref","first-page":"106961","DOI":"10.1016\/j.jddst.2025.106961","article-title":"Unlocking the human blood-brain barrier (BBB) characteristics for the development of nano-delivery strategies for central nervous system therapies","volume":"108","author":"Gokce","year":"2025","journal-title":"Journal of Drug Delivery Science and Technology"},{"issue":"3","key":"10.1016\/j.ejpb.2026.115120_b0020","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1208\/s12249-026-03386-7","article-title":"Breaking the barrier of brain disease therapeutics: Advocating targeted drug delivery for improved neuro-resident interventions","volume":"27","author":"Kariithi","year":"2026","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ejpb.2026.115120_b0025","doi-asserted-by":"crossref","DOI":"10.1080\/21688370.2025.2599564","article-title":"Nanoparticle-based strategies for overcoming the blood-brain barrier in CNS disorders and brain cancer: precision diagnostics and therapeutics for Alzheimer\u2019s, Parkinson\u2019s, multiple sclerosis, and glioblastoma","author":"Feyzbakhsh","year":"2025","journal-title":"Tissue Barriers"},{"key":"10.1016\/j.ejpb.2026.115120_b0030","doi-asserted-by":"crossref","unstructured":"M.D. Zabel, Lipopeptide delivery of siRNA to the central nervous system, Nanotechnology for Nucleic Acid Delivery: Methods and Protocols, Springer2012, pp. 251\u2013262, doi: 10.1007\/978-1-62703-140-0_17.","DOI":"10.1007\/978-1-62703-140-0_17"},{"issue":"15","key":"10.1016\/j.ejpb.2026.115120_b0035","doi-asserted-by":"crossref","first-page":"987","DOI":"10.2174\/0113894501312703240826070530","article-title":"Trends on novel targets and nanotechnology-based drug delivery system in the treatment of Parkinson\u2019s disease: Recent advancement in drug development","volume":"25","author":"Majumdar","year":"2024","journal-title":"Current Drug Targets"},{"key":"10.1016\/j.ejpb.2026.115120_b0040","doi-asserted-by":"crossref","first-page":"611367","DOI":"10.3389\/fmolb.2021.611367","article-title":"A nanomule peptide carrier delivers siRNA across the intact blood-brain barrier to attenuate ischemic stroke","volume":"8","author":"Eyford","year":"2021","journal-title":"Frontiers in Molecular Biosciences"},{"issue":"1","key":"10.1016\/j.ejpb.2026.115120_b0045","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.expneurol.2005.04.008","article-title":"An active transport system in the blood\u2013brain barrier may reduce levodopa availability","volume":"195","author":"Hawkins","year":"2005","journal-title":"Experimental Neurology"},{"issue":"3","key":"10.1016\/j.ejpb.2026.115120_b0050","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s00018-013-1397-y","article-title":"m.l. sciences, Temozolomide down-regulates P-glycoprotein in human blood\u2013brain barrier cells by disrupting Wnt3 signaling","volume":"71","author":"Riganti","year":"2014","journal-title":"Cellular and Molecular Life Sciences"},{"issue":"2","key":"10.1016\/j.ejpb.2026.115120_b0055","doi-asserted-by":"crossref","DOI":"10.1093\/jpp\/rgaf099","article-title":"Pharmacology, In vitro assessment of P-glycoprotein-mediated antiseizure medications efflux in a blood\u2013brain barrier cell model","volume":"78","author":"Paul","year":"2026","journal-title":"Journal of Pharmacy and Pharmacology"},{"issue":"1","key":"10.1016\/j.ejpb.2026.115120_b0060","article-title":"Bypassing P\u2010glycoprotein drug efflux mechanisms: Possible applications in Pharmacoresistant schizophrenia therapy","volume":"2015","author":"Hoosain","year":"2015","journal-title":"BioMed Research International"},{"issue":"10","key":"10.1016\/j.ejpb.2026.115120_b0065","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1517\/17425247.5.10.1159","article-title":"From nose to brain: understanding transport capacity and transport rate of drugs","volume":"5","author":"Wu","year":"2008","journal-title":"Expert Opinion on Drug Delivery"},{"key":"10.1016\/j.ejpb.2026.115120_b0070","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.lfs.2017.12.025","article-title":"Mechanism of intranasal drug delivery directly to the brain","volume":"195","author":"Crowe","year":"2018","journal-title":"Life Sciences"},{"issue":"5","key":"10.1016\/j.ejpb.2026.115120_b0075","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1208\/s12249-024-02810-0","article-title":"In-depth mechanism, challenges, and opportunities of delivering therapeutics in brain using intranasal route","volume":"25","author":"Ghosh","year":"2024","journal-title":"AAPS PharmSciTech"},{"issue":"6","key":"10.1016\/j.ejpb.2026.115120_b0080","doi-asserted-by":"crossref","first-page":"775","DOI":"10.3390\/pharmaceutics17060775","article-title":"Intranasal drug delivery technology in the treatment of central nervous system diseases: Challenges, advances, and future research directions","volume":"17","author":"Wu","year":"2025","journal-title":"Pharmaceutics"},{"issue":"6","key":"10.1016\/j.ejpb.2026.115120_b0085","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.70213","article-title":"The Nasal\u2013brain drug delivery route: mechanisms and applications to central nervous system diseases","volume":"6","author":"Qiu","year":"2025","journal-title":"MedComm"},{"issue":"11","key":"10.1016\/j.ejpb.2026.115120_b0090","doi-asserted-by":"crossref","first-page":"598","DOI":"10.3390\/pharmaceutics11110598","article-title":"Perivascular and perineural pathways involved in brain delivery and distribution of drugs after intranasal administration","volume":"11","author":"Lochhead","year":"2019","journal-title":"Pharmaceutics"},{"issue":"6","key":"10.1016\/j.ejpb.2026.115120_b0095","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1080\/17425247.2025.2489553","article-title":"The nasal route for nose-to-brain drug delivery: advanced nasal formulations for CNS disorders","volume":"22","author":"Papakyriakopoulou","year":"2025","journal-title":"Expert Opinion on Drug Delivery"},{"key":"10.1016\/j.ejpb.2026.115120_b0100","doi-asserted-by":"crossref","first-page":"123809","DOI":"10.1016\/j.ijpharm.2024.123809","article-title":"Rivastigmine nasal spray for the treatment of Alzheimer\u2019s Disease: Olfactory deposition and brain delivery","volume":"652","author":"Guo","year":"2024","journal-title":"International Journal of Pharmaceutics"},{"issue":"5","key":"10.1016\/j.ejpb.2026.115120_b0105","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1111\/head.13309","article-title":"DFN\u201002 (sumatriptan 10 mg with a permeation enhancer) nasal spray vs placebo in the acute treatment of migraine: A double\u2010blind, placebo\u2010controlled study","volume":"58","author":"Lipton","year":"2018","journal-title":"The Journal of Head and Face Pain"},{"issue":"12","key":"10.1016\/j.ejpb.2026.115120_b0110","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1080\/17512433.2017.1394185","article-title":"Desmopressin acetate nasal spray for adults with nocturia","volume":"10","author":"Cohn","year":"2017","journal-title":"Expert Review of Clinical Pharmacology"},{"issue":"4","key":"10.1016\/j.ejpb.2026.115120_b0115","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/s40267-018-0498-y","article-title":"Naloxone nasal spray (Nyxoid\u00ae) in opioid overdose: A profile of its use in the EU","volume":"34","author":"McKeage","year":"2018","journal-title":"Drugs & Therapy Perspectives"},{"issue":"6","key":"10.1016\/j.ejpb.2026.115120_b0120","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1080\/17425247.2025.2489553","article-title":"The nasal route for nose-to-brain drug delivery: advanced nasal formulations for CNS disorders","volume":"22","author":"Papakyriakopoulou","year":"2025","journal-title":"Expert Opinion on Drug Delivery"},{"issue":"10","key":"10.1016\/j.ejpb.2026.115120_b0125","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1007\/s11095-012-0915-1","article-title":"Intranasal treatment of central nervous system dysfunction in humans","volume":"30","author":"Chapman","year":"2013","journal-title":"Pharmaceutical Research"},{"issue":"101631","key":"10.1016\/j.ejpb.2026.115120_b0130","first-page":"2022","article-title":"On a highway to the brain: A review on nose-to-brain drug delivery using nanoparticles","volume":"29","author":"Formica","year":"2022","journal-title":"Applied Materials Today"},{"issue":"1","key":"10.1016\/j.ejpb.2026.115120_b0135","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s40005-022-00589-5","article-title":"Drug delivery to the brain via the nasal route of administration: exploration of key targets and major consideration factors","volume":"53","author":"Jeong","year":"2023","journal-title":"Journal of Pharmaceutical Investigation"},{"issue":"5","key":"10.1016\/j.ejpb.2026.115120_b0140","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1172\/JCI0215217","article-title":"Mucus clearance as a primary innate defense mechanism for mammalian airways","volume":"109","author":"Knowles","year":"2002","journal-title":"The Journal of Clinical Investigation"},{"issue":"3","key":"10.1016\/j.ejpb.2026.115120_b0145","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3390\/encyclopedia5030091","article-title":"Nose-to-brain drug delivery","volume":"5","author":"Nguyen","year":"2025","journal-title":"Encyclopedia"},{"key":"10.1016\/j.ejpb.2026.115120_b0150","doi-asserted-by":"crossref","first-page":"145987","DOI":"10.1016\/j.ijbiomac.2025.145987","article-title":"A comprehensive review on natural polysaccharides based in situ gels for nasal drug delivery","author":"Sonawane","year":"2025","journal-title":"International Journal of Biological Macromolecules"},{"issue":"19","key":"10.1016\/j.ejpb.2026.115120_b0155","doi-asserted-by":"crossref","first-page":"5905","DOI":"10.3390\/molecules26195905","article-title":"Controlled drug delivery systems: current status and future directions","volume":"26","author":"Adepu","year":"2021","journal-title":"Molecules"},{"issue":"2","key":"10.1016\/j.ejpb.2026.115120_b0160","first-page":"e1756","article-title":"Nanobiotechnology, Nanocarrier\u2010hydrogel composite delivery systems for precision drug release","volume":"14","author":"Kass","year":"2022","journal-title":"Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology"},{"issue":"3","key":"10.1016\/j.ejpb.2026.115120_b0165","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3390\/gels3030025","article-title":"Polymeric hydrogels as technology platform for drug delivery applications","volume":"3","author":"Sosnik","year":"2017","journal-title":"Gels"},{"key":"10.1016\/j.ejpb.2026.115120_b0170","doi-asserted-by":"crossref","first-page":"838","DOI":"10.3390\/gels9100838","article-title":"Current advances in stimuli-responsive hydrogels as smart drug delivery carriers","volume":"9","author":"Zhang","year":"2023","journal-title":"Gels"},{"key":"10.1016\/j.ejpb.2026.115120_b0175","doi-asserted-by":"crossref","first-page":"123819","DOI":"10.1016\/j.ijpharm.2024.123819","article-title":"In-situ gel: A smart carrier for drug delivery","volume":"652","author":"Garg","year":"2024","journal-title":"International Journal of Pharmaceutics"},{"issue":"3","key":"10.1016\/j.ejpb.2026.115120_b0180","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0169-409X(01)00203-4","article-title":"Environment-sensitive hydrogels for drug delivery","volume":"53","author":"Qiu","year":"2001","journal-title":"Advanced Drug Delivery Reviews"},{"issue":"8","key":"10.1016\/j.ejpb.2026.115120_b0185","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1517\/17425247.2011.581656","article-title":"Thermosensitive hydrogels for drug delivery","volume":"8","author":"Li","year":"2011","journal-title":"Expert Opinion on Drug Delivery"},{"key":"10.1016\/j.ejpb.2026.115120_b0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioadv.2023.213722","article-title":"Mucin-mediated mucosal retention via end-terminal modified Pluronic F127-based hydrogel to increase drug accumulation in the lungs","volume":"156","author":"Wu","year":"2024","journal-title":"Biomaterials Advances"},{"issue":"6","key":"10.1016\/j.ejpb.2026.115120_b0195","doi-asserted-by":"crossref","first-page":"871","DOI":"10.3390\/ph18060871","article-title":"Thermosensitive mucoadhesive intranasal in situ gel of risperidone for nose-to-brain targeting: Physiochemical and pharmacokinetics study","volume":"18","author":"Singh","year":"2025","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ejpb.2026.115120_b0200","first-page":"e55","volume":"2(3)","author":"Khan","year":"2023","journal-title":"Recent progress in thermosensitive hydrogels and their applications in drug delivery area, MedComm\u2013Biomaterials and Applications"},{"issue":"7","key":"10.1016\/j.ejpb.2026.115120_b0205","doi-asserted-by":"crossref","first-page":"544","DOI":"10.3390\/gels11070544","article-title":"A comprehensive review of thermosensitive hydrogels: Mechanism, optimization strategies, and applications","volume":"11","author":"Lv","year":"2025","journal-title":"Gels"},{"key":"10.1016\/j.ejpb.2026.115120_b0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2025.145647","article-title":"Formulation and evaluation of in-situ forming poloxamer-based hydrogel containing thiolated chitosan nanoparticles as intranasal galantamine delivery system","volume":"320","author":"Lotfi","year":"2025","journal-title":"International Journal of Biological Macromolecules"},{"issue":"10","key":"10.1016\/j.ejpb.2026.115120_b0215","doi-asserted-by":"crossref","first-page":"841","DOI":"10.3390\/gels11100841","article-title":"Investigation of rheological characteristics of thermosensitive nasal in situ gels based on P407 and their effect on spray pattern","volume":"11","author":"Menshutina","year":"2025","journal-title":"Gels"},{"key":"10.1016\/j.ejpb.2026.115120_b0220","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ijpharm.2019.01.030","article-title":"Updates on thermosensitive hydrogel for nasal, ocular and cutaneous delivery","volume":"559","author":"Wang","year":"2019","journal-title":"International Journal of Pharmaceutics"},{"issue":"24","key":"10.1016\/j.ejpb.2026.115120_b0225","doi-asserted-by":"crossref","first-page":"5353","DOI":"10.3390\/polym14245353","article-title":"Investigation and characterization of factors affecting rheological properties of poloxamer-based thermo-sensitive hydrogel","volume":"14","author":"Chen","year":"2022","journal-title":"Polymers"},{"key":"10.1016\/j.ejpb.2026.115120_b0230","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ejpb.2023.01.007","article-title":"Biopharmaceutics, In situ gelling drug delivery systems for topical drug delivery","volume":"184","author":"Kolawole","year":"2023","journal-title":"European Journal of Pharmaceutics and Biopharmaceutics"},{"issue":"10","key":"10.1016\/j.ejpb.2026.115120_b0235","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.3390\/polym13101641","article-title":"Recent developments in ion-sensitive systems for pharmaceutical applications","volume":"13","author":"Rudko","year":"2021","journal-title":"Polymers"},{"issue":"4","key":"10.1016\/j.ejpb.2026.115120_b0240","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1021\/acsbiomaterials.1c00116","article-title":"Recent development of alginate-based materials and their versatile functions in biomedicine, flexible electronics, and environmental uses","volume":"7","author":"Teng","year":"2021","journal-title":"ACS Biomaterials Science & Engineering"},{"issue":"1","key":"10.1016\/j.ejpb.2026.115120_b0245","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s12247-025-10276-1","article-title":"Ion-sensitive in-situ nasal gel of edaravone nanosuspension for brain targeting","volume":"21","author":"Patel","year":"2026","journal-title":"Journal of Pharmaceutical Innovation"},{"issue":"6","key":"10.1016\/j.ejpb.2026.115120_b0250","doi-asserted-by":"crossref","first-page":"404","DOI":"10.3390\/gels11060404","article-title":"Gellan gum-based in situ hydrogels for nasal delivery of polymeric micelles loaded with risperidone","volume":"11","author":"Sipos","year":"2025","journal-title":"Gels"},{"issue":"4","key":"10.1016\/j.ejpb.2026.115120_b0255","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3390\/gels11040293","article-title":"Advancements and prospects of pH-responsive hydrogels in biomedicine","volume":"11","author":"Gao","year":"2025","journal-title":"Gels"},{"issue":"2","key":"10.1016\/j.ejpb.2026.115120_b0260","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1080\/17425247.2025.2583254","article-title":"Challenges and strategies for nose-to-brain delivery in treating neurological disorders","volume":"23","author":"Li","year":"2026","journal-title":"Expert Opinion on Drug Delivery"},{"issue":"4","key":"10.1016\/j.ejpb.2026.115120_b0265","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3390\/gels11040241","article-title":"Preparation of pH-sensitive poly (N-(2-Hydroxyethyl) acrylamide-co-acrylic acid) hydrogels and their performance","volume":"11","author":"Liu","year":"2025","journal-title":"Gels"},{"issue":"4","key":"10.1016\/j.ejpb.2026.115120_b0270","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3390\/polym9040137","article-title":"pH sensitive hydrogels in drug delivery: Brief history, properties, swelling, and release mechanism, material selection and applications","volume":"9","author":"Rizwan","year":"2017","journal-title":"Polymers"},{"issue":"2","key":"10.1016\/j.ejpb.2026.115120_b0280","doi-asserted-by":"crossref","first-page":"249","DOI":"10.3390\/pharmaceutics17020249","article-title":"Gels as promising delivery systems: Physicochemical property characterization and recent applications","volume":"17","author":"Wang","year":"2025","journal-title":"Pharmaceutics"},{"issue":"6","key":"10.1016\/j.ejpb.2026.115120_b0285","doi-asserted-by":"crossref","first-page":"681","DOI":"10.3390\/polym18060681","article-title":"Polymer matrices for reversible thermogelling hydrogels: Principles, fabrication, and drug delivery prospects","volume":"18","author":"Pyzhov","year":"2026","journal-title":"Polymers"},{"issue":"1","key":"10.1016\/j.ejpb.2026.115120_b0290","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3390\/polysaccharides6010006","article-title":"Polysaccharides: New frontiers for nasal administration of medicines","volume":"6","author":"Clementino","year":"2025","journal-title":"Polysaccharides"},{"issue":"2","key":"10.1016\/j.ejpb.2026.115120_b0295","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1007\/s40199-024-00543-w","article-title":"Recent opportunities and application of gellan gum based drug delivery system for intranasal route","volume":"32","author":"Garg","year":"2024","journal-title":"DARU Journal of Pharmaceutical Sciences"},{"issue":"2","key":"10.1016\/j.ejpb.2026.115120_b0300","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1080\/17425247.2025.2583254","article-title":"Challenges and strategies for nose-to-brain delivery in treating neurological disorders","volume":"23","author":"Li","year":"2026","journal-title":"Expert Opinion on Drug Delivery"},{"key":"10.1016\/j.ejpb.2026.115120_b0305","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jconrel.2017.02.021","article-title":"Revisiting structure-property relationship of pH-responsive polymers for drug delivery applications","volume":"253","author":"Bazban-Shotorbani","year":"2017","journal-title":"Journal of Controlled Release"},{"issue":"7","key":"10.1016\/j.ejpb.2026.115120_b0310","doi-asserted-by":"crossref","first-page":"3665","DOI":"10.3390\/ijms23073665","article-title":"Smart hydrogels for advanced drug delivery systems","volume":"23","author":"Bordbar-Khiabani","year":"2022","journal-title":"International Journal of Molecular Sciences"},{"issue":"1","key":"10.1016\/j.ejpb.2026.115120_b0315","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1208\/s12249-020-01872-0","article-title":"Patient-friendly, olfactory-targeted, stimuli-responsive hydrogels for cerebral degenerative disorders ensured> 400% brain targeting efficiency in rats","volume":"22","author":"Nafee","year":"2020","journal-title":"AAPS PharmSciTech"},{"issue":"38","key":"10.1016\/j.ejpb.2026.115120_b0275","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202416085","article-title":"Conductive nanocomposite hydrogels for neural tissue engineering: A systematic scoping review of recent trends","volume":"12","author":"Moghaddasi","year":"2025","journal-title":"Advanced Science"},{"issue":"4","key":"10.1016\/j.ejpb.2026.115120_b0320","doi-asserted-by":"crossref","first-page":"481","DOI":"10.3390\/pharmaceutics16040481","article-title":"Nasal delivery to the brain: harnessing nanoparticles for effective drug transport","volume":"16","author":"Gandhi","year":"2024","journal-title":"Pharmaceutics"},{"issue":"11","key":"10.1016\/j.ejpb.2026.115120_b0325","doi-asserted-by":"crossref","first-page":"2102610","DOI":"10.1002\/adhm.202102610","article-title":"Intranasal delivery of functionalized polymeric nanomaterials to the brain","volume":"11","author":"Zha","year":"2022","journal-title":"Advanced Healthcare Materials"},{"issue":"11","key":"10.1016\/j.ejpb.2026.115120_b0330","doi-asserted-by":"crossref","first-page":"683","DOI":"10.4155\/tde-2019-0060","article-title":"Formulation of polymeric nanoparticles of antidepressant drug for intranasal delivery","volume":"10","author":"Jani","year":"2019","journal-title":"Therapeutic Delivery"},{"key":"10.1016\/j.ejpb.2026.115120_b0335","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2023.113328","article-title":"Pluronic F127 coating performance on PLGA nanoparticles: enhanced flocculation and instability","volume":"226","author":"Li","year":"2023","journal-title":"Colloids and Surfaces B: Biointerfaces"},{"issue":"5","key":"10.1016\/j.ejpb.2026.115120_b0340","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.1600519","article-title":"Encapsulation-free controlled release: Electrostatic adsorption eliminates the need for protein encapsulation in PLGA nanoparticles","volume":"2","author":"Pakulska","year":"2016","journal-title":"Science Advances"},{"issue":"18","key":"10.1016\/j.ejpb.2026.115120_b0345","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e38165","article-title":"The drug release of PLGA-based nanoparticles and their application in treatment of gastrointestinal cancers","volume":"10","author":"Sun","year":"2024","journal-title":"Heliyon"},{"issue":"7","key":"10.1016\/j.ejpb.2026.115120_b0350","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1208\/s12249-024-02917-4","article-title":"PLGA nanoparticles based mucoadhesive nasal in situ gel for enhanced brain delivery of topiramate","volume":"25","author":"Tanna","year":"2024","journal-title":"AAPS PharmSciTech"},{"issue":"7","key":"10.1016\/j.ejpb.2026.115120_b0355","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1007\/s11064-024-04129-5","article-title":"Binary nano-inhalant formulation of icariin enhances cognitive function in vascular dementia via BDNF\/TrkB signaling and anti-inflammatory effects","volume":"49","author":"Li","year":"2024","journal-title":"Neurochemical Research"},{"issue":"4","key":"10.1016\/j.ejpb.2026.115120_b0360","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s13205-020-2144-3","article-title":"Recent strategies towards the surface modification of liposomes: an innovative approach for different clinical applications","volume":"10","author":"Khan","year":"2020","journal-title":"3 Biotech"},{"key":"10.1016\/j.ejpb.2026.115120_b0365","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.2147\/IJN.S439181","article-title":"Recent advances in intranasal administration for brain-targeting delivery: A comprehensive review of lipid-based nanoparticles and stimuli-responsive gel formulations","author":"Koo","year":"2024","journal-title":"International Journal of Nanomedicine"},{"key":"10.1016\/j.ejpb.2026.115120_b0370","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ejpb.2019.12.014","article-title":"Biopharmaceutics, Progress and perspectives of brain-targeting lipid-based nanosystems via the nasal route in Alzheimer\u2019s disease","volume":"148","author":"Akel","year":"2020","journal-title":"European Journal of Pharmaceutics and Biopharmaceutics"},{"issue":"2","key":"10.1016\/j.ejpb.2026.115120_b0375","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1080\/08982104.2024.2431908","article-title":"Surface-modified liposomal in-situ nasal gel enhances brain targeting of berberine hydrochloride for Alzheimer\u2019s therapy: optimization and in vivo studies","volume":"35","author":"Bahndare","year":"2025","journal-title":"Journal of Liposome Research"},{"key":"10.1016\/j.ejpb.2026.115120_b0380","first-page":"1","article-title":"Therapy, Co-encapsulation in solid lipid nanoparticles and nanostructured lipid carriers as an emerging therapeutic strategy: J. Torres et al","author":"Torres","year":"2026","journal-title":"Molecular Diagnosis & Therapy"},{"issue":"3","key":"10.1016\/j.ejpb.2026.115120_b0385","doi-asserted-by":"crossref","first-page":"633","DOI":"10.3390\/antiox12030633","article-title":"Solid lipid nanoparticles: review of the current research on encapsulation and delivery systems for active and antioxidant compounds","volume":"12","author":"Subroto","year":"2023","journal-title":"Antioxidants"},{"key":"10.1016\/j.ejpb.2026.115120_b0390","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ejpb.2017.03.010","article-title":"Biopharmaceutics, Evaluation of the drug loading capacity of different lipid nanoparticle dispersions by passive drug loading","volume":"117","author":"Rosenblatt","year":"2017","journal-title":"European Journal of Pharmaceutics and Biopharmaceutics"},{"issue":"1","key":"10.1016\/j.ejpb.2026.115120_b0395","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s43094-022-00414-8","article-title":"Nanostructured lipid carriers: A promising drug carrier for targeting brain tumours","volume":"8","author":"Garg","year":"2022","journal-title":"Future Journal of Pharmaceutical Sciences"},{"issue":"9","key":"10.1016\/j.ejpb.2026.115120_b0400","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s12272-016-0782-0","article-title":"Hydrogel nanoparticles and nanocomposites for nasal drug\/vaccine delivery","volume":"39","author":"Salatin","year":"2016","journal-title":"Archives of Pharmacal Research"},{"issue":"4","key":"10.1016\/j.ejpb.2026.115120_b0405","doi-asserted-by":"crossref","first-page":"118","DOI":"10.3390\/ph11040118","article-title":"Lipid nanoparticles and their hydrogel composites for drug delivery: A review","volume":"11","author":"Desfran\u00e7ois","year":"2018","journal-title":"Pharmaceuticals"},{"issue":"2","key":"10.1016\/j.ejpb.2026.115120_b0410","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1208\/s12249-024-02736-7","article-title":"Quercetin-loaded nanostructured lipid carrier in situ gel for brain targeting through intranasal route: Formulation, in vivo pharmacokinetic and pharmacodynamic studies","volume":"25","author":"Sonawane","year":"2024","journal-title":"AAPS PharmSciTech"},{"issue":"5","key":"10.1016\/j.ejpb.2026.115120_b0415","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1089\/adt.2022.044","article-title":"Formulation and characterization of nanostructured lipid carriers of rizatriptan benzoate-loaded in situ nasal gel for brain targeting","volume":"20","author":"Mathure","year":"2022","journal-title":"ASSAY and Drug Development Technologies"},{"key":"10.1016\/j.ejpb.2026.115120_b0420","doi-asserted-by":"crossref","first-page":"123345","DOI":"10.1016\/j.ijpharm.2023.123345","article-title":"In situ hydrogel containing diazepam-loaded nanostructured lipid carriers (DZP-NLC) for nose-to-brain delivery: development, characterization and deposition studies in a 3D-printed human nasal cavity model","volume":"644","author":"Costa","year":"2023","journal-title":"International Journal of Pharmaceutics"},{"key":"10.1016\/j.ejpb.2026.115120_b0425","doi-asserted-by":"crossref","DOI":"10.1016\/j.nsa.2024.104062","article-title":"Nose to brain delivery of flurbiprofen from a solid lipid nanoparticles-based thermosensitive in-situ gel","volume":"3","author":"Choudhary","year":"2024","journal-title":"Neuroscience Applied"},{"issue":"1","key":"10.1016\/j.ejpb.2026.115120_b0430","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s12247-025-10263-6","article-title":"Development of a gellan\u2013carbopol in situ gel system for intranasal delivery of artemether-loaded SLNs: Optimization and kinetic evaluation","volume":"21","author":"Bhute","year":"2026","journal-title":"Journal of Pharmaceutical Innovation"},{"key":"10.1016\/j.ejpb.2026.115120_b0435","doi-asserted-by":"crossref","first-page":"126285","DOI":"10.1016\/j.ijpharm.2025.126285","article-title":"Rhynchophylline self-micelle solid dispersion integrated in situ gel against Parkinson\u2019s disease by intranasal delivery","author":"Kong","year":"2025","journal-title":"International Journal of Pharmaceutics"},{"key":"10.1016\/j.ejpb.2026.115120_b0440","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119046","article-title":"Facile nose-to-brain delivery of rotigotine-loaded polymer micelles thermosensitive hydrogels: In vitro characterization and in vivo behavior study","volume":"577","author":"Wang","year":"2020","journal-title":"International Journal of Pharmaceutics"},{"key":"10.1016\/j.ejpb.2026.115120_b0445","article-title":"A thermosensitive chitosan hydrogel: An attempt for the nasal delivery of dimethyl fumarate","volume":"278","author":"Gonz\u00e1lez","year":"2024","journal-title":"International Journal of Biological Macromolecules"},{"key":"10.1016\/j.ejpb.2026.115120_b0450","article-title":"Nanosystems for Intranasal delivery of therapeutics in psychiatric disorders","author":"Hamidi","year":"2025","journal-title":"Current Drug Delivery"},{"key":"10.1016\/j.ejpb.2026.115120_b0455","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.134385","article-title":"In situ-gelling hydrophobized starch nanoparticle-based nanoparticle network hydrogels for the effective delivery of intranasal olanzapine to treat brain disorders","volume":"277","author":"Lofts","year":"2024","journal-title":"International Journal of Biological Macromolecules"},{"issue":"50","key":"10.1016\/j.ejpb.2026.115120_b0475","doi-asserted-by":"crossref","first-page":"35251","DOI":"10.1039\/D3RA07391B","article-title":"Revolutionizing biomedicine: advancements, applications, and prospects of nanocomposite macromolecular carbohydrate-based hydrogel biomaterials: a review","volume":"13","author":"Alshangiti","year":"2023","journal-title":"RSC Advances"},{"key":"10.1016\/j.ejpb.2026.115120_b0480","doi-asserted-by":"crossref","first-page":"121720","DOI":"10.1016\/j.ijpharm.2022.121720","article-title":"Thermosensitive in situ hydrogels of rivastigmine-loaded lipid-based nanosystems for nose-to-brain delivery: Characterisation, biocompatibility, and drug deposition studies","volume":"620","author":"Cunha","year":"2022","journal-title":"International Journal of Pharmaceutics"},{"key":"10.1016\/j.ejpb.2026.115120_b0485","doi-asserted-by":"crossref","unstructured":"M.U. Rehman Kashif, M. Sohail, A. Mahmood, S. A. Shah, M. Abbasi, M. Kousar, Nose-to-brain delivery of nano-engineered biomaterials for effective targeting to the brainInternational, Journal of Polymeric Materials and Polymeric Biomaterials 74 (10) 899\u2013922, doi: 10.1080\/00914037.2024.2383412.","DOI":"10.1080\/00914037.2024.2383412"},{"key":"10.1016\/j.ejpb.2026.115120_b0490","article-title":"Quercetin-loaded zeolitic imidazolate framework-8 nanoparticles through borneol-embedded hyaluronic acid hydrogel for ischemic stroke treatment","author":"Yu","year":"2025","journal-title":"International Journal of Biological Macromolecules"},{"issue":"11","key":"10.1016\/j.ejpb.2026.115120_b0460","doi-asserted-by":"crossref","first-page":"892","DOI":"10.3390\/gels11110892","article-title":"Multifunctional nanomaterial-integrated hydrogels for sustained drug delivery: From synthesis and characterization to biomedical application","volume":"11","author":"Stevanovi\u0107","year":"2025","journal-title":"Gels"},{"issue":"7","key":"10.1016\/j.ejpb.2026.115120_b0465","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.3390\/biomedicines10071706","article-title":"Micro-and nanosized carriers for nose-to-brain drug delivery in neurodegenerative disorders","volume":"10","author":"Boyuklieva","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.ejpb.2026.115120_b0470","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/01932691.2025.2532540","article-title":"Technology, Nose to brain delivery of thermosensitive hydrogel system containing riluzole nanosuspension: design, physicochemical characterization and antidepressant efficacy","author":"Taymouri","year":"2025","journal-title":"Journal of Dispersion Science and Technology"},{"issue":"2","key":"10.1016\/j.ejpb.2026.115120_b0495","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0378-5173(95)04115-X","article-title":"Bioadhesive and formulation parameters affecting nasal absorption","volume":"127","author":"Dondeti","year":"1996","journal-title":"International Journal of Pharmaceutics"},{"issue":"3","key":"10.1016\/j.ejpb.2026.115120_b0500","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s40005-020-00482-z","article-title":"Factors influencing drug deposition in the nasal cavity upon delivery via nasal sprays","volume":"50","author":"Gao","year":"2020","journal-title":"Journal of Pharmaceutical Investigation"},{"issue":"6","key":"10.1016\/j.ejpb.2026.115120_b0505","doi-asserted-by":"crossref","DOI":"10.1002\/mame.202400356","article-title":"In situ gels for nasal delivery: Formulation, characterization and applications","volume":"310","author":"Qian","year":"2025","journal-title":"Macromolecular Materials and Engineering"},{"issue":"9","key":"10.1016\/j.ejpb.2026.115120_b0510","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.3390\/pharmaceutics14091870","article-title":"Nose-to-brain delivery of therapeutic peptides as nasal aerosols","volume":"14","author":"Alabsi","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2026.115120_b0610","article-title":"Macro-micro spray characteristics of nasal spray: Bridging physicochemical properties to precision olfactory delivery","volume":"112085","author":"Kong","year":"2025","journal-title":"Chinese Chemical Letters"},{"key":"10.1016\/j.ejpb.2026.115120_b0515","doi-asserted-by":"crossref","unstructured":"J.D. Ehrick, S.A. Shah, C. Shaw, V.S. Kulkarni, I. Coowanitwong, S. De, J.D. Suman, Considerations for the development of nasal dosage forms, Sterile Product Development: Formulation, Process, Quality and Regulatory Considerations, Springer2013, pp. 99-144. https:\/\/doi.org\/10.1007\/978-1-4614-7978-9_5.","DOI":"10.1007\/978-1-4614-7978-9_5"},{"issue":"2","key":"10.1016\/j.ejpb.2026.115120_b0520","doi-asserted-by":"crossref","first-page":"246","DOI":"10.3390\/pharmaceutics13020246","article-title":"Current perspective on nasal delivery systems for chronic rhinosinusitis","volume":"13","author":"Tai","year":"2021","journal-title":"Pharmaceutics"},{"issue":"7","key":"10.1016\/j.ejpb.2026.115120_b0525","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.3390\/pharmaceutics13071079","article-title":"In vitro evaluation of nasal aerosol depositions: an insight for direct nose to brain drug delivery","volume":"13","author":"Maaz","year":"2021","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.ejpb.2026.115120_b0530","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1089\/jamp.2013.1093","article-title":"Measurements of droplet size distribution and analysis of nasal spray atomization from different actuation pressure","volume":"28","author":"Inthavong","year":"2015","journal-title":"Journal of Aerosol Medicine and Pulmonary Drug Delivery"},{"issue":"7","key":"10.1016\/j.ejpb.2026.115120_b0535","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1208\/s12249-023-02665-x","article-title":"Laboratory performance testing of aqueous nasal inhalation products for droplet\/particle size distribution: An assessment from the international pharmaceutical aerosol consortium on regulation and science (IPAC-RS)","volume":"24","author":"Doub","year":"2023","journal-title":"AAPS PharmSciTech"},{"issue":"1","key":"10.1016\/j.ejpb.2026.115120_b0545","doi-asserted-by":"crossref","first-page":"4099","DOI":"10.1038\/s41598-023-30252-4","article-title":"Computational optimization of delivery parameters to guide the development of targeted Nasal spray","volume":"13","author":"Du","year":"2023","journal-title":"Scientific Reports"},{"issue":"7","key":"10.1016\/j.ejpb.2026.115120_b0550","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1208\/s12249-018-1031-2","article-title":"A simplified geometric model to predict nasal spray deposition in children and adults","volume":"19","author":"Foo","year":"2018","journal-title":"AAPS Pharmscitech"},{"issue":"6","key":"10.1016\/j.ejpb.2026.115120_b0555","doi-asserted-by":"crossref","first-page":"903","DOI":"10.3390\/pharmaceutics13060903","article-title":"Liquid film translocation significantly enhances nasal spray delivery to olfactory region: a numerical simulation study","volume":"13","author":"Si","year":"2021","journal-title":"Pharmaceutics"},{"issue":"2","key":"10.1016\/j.ejpb.2026.115120_b0595","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3390\/ph19020217","article-title":"Experimentally informed numerical simulations of spray deposition and runoff doses in a 10-Day-old nose model","volume":"19","author":"Zhang","year":"2026","journal-title":"Pharmaceuticals"},{"issue":"1","key":"10.1016\/j.ejpb.2026.115120_b0600","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3390\/pharmaceutics16010002","article-title":"Improved olfactory deposition of theophylline using a nanotech soft mist nozzle chip","volume":"16","author":"Zhang","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2026.115120_b0605","doi-asserted-by":"crossref","first-page":"O11","DOI":"10.1186\/1753-6561-9-S9-O11","article-title":"Protein aerosol for intranasal nose to brain (N2B) delivery","author":"St\u00fctzle","year":"2015","journal-title":"BMC Proceedings, Springer"},{"key":"10.1016\/j.ejpb.2026.115120_b0540","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.17227","article-title":"Comparative study of nasal cavity drug delivery efficiency with different nozzles in a 3D printed model","volume":"12","author":"Fang","year":"2024","journal-title":"PeerJ"},{"issue":"1\u20132","key":"10.1016\/j.ejpb.2026.115120_b0560","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ijpharm.2015.02.065","article-title":"The effect of shear and extensional viscosities on atomization of Newtonian and non-Newtonian fluids in ultrasonic inhaler","volume":"485","author":"Broniarz-Press","year":"2015","journal-title":"International Journal of Pharmaceutics"},{"issue":"2","key":"10.1016\/j.ejpb.2026.115120_b0565","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3390\/liquids5020011","article-title":"Enhancing physiological realism in nasal spray deposition studies: Synthetic mucus properties and interactions with saline solutions and stereolithography resin","volume":"5","author":"Seifelnasr","year":"2025","journal-title":"Liquids"},{"issue":"9","key":"10.1016\/j.ejpb.2026.115120_b0570","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1081\/DDC-100101325","article-title":"Rheological behavior of nasal sprays in shear and extension","volume":"26","author":"Eccleston","year":"2000","journal-title":"Drug Development and Industrial Pharmacy"},{"issue":"4","key":"10.1016\/j.ejpb.2026.115120_b0575","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1007\/s00405-015-3701-y","article-title":"The administration of nasal drops in the \u201cKaiteki\u201d position allows for delivery of the drug to the olfactory cleft: a pilot study in healthy subjects","volume":"273","author":"Mori","year":"2016","journal-title":"European Archives of Oto-Rhino-Laryngology"},{"key":"10.1016\/j.ejpb.2026.115120_b0580","first-page":"48","article-title":"Computed intranasal spray penetration: comparisons before and after nasal surgery, International Forum of Allergy & Rhinology","author":"Frank","year":"2013","journal-title":"Wiley Online Library"},{"key":"10.1016\/j.ejpb.2026.115120_b0585","doi-asserted-by":"crossref","first-page":"118911","DOI":"10.1016\/j.ijpharm.2019.118911","article-title":"Impact of physicochemical properties of nasal spray products on drug deposition and transport in the pediatric nasal cavity model","volume":"574","author":"Sosnowski","year":"2020","journal-title":"International Journal of Pharmaceutics"},{"issue":"5","key":"10.1016\/j.ejpb.2026.115120_b0590","doi-asserted-by":"crossref","first-page":"956","DOI":"10.3390\/pharmaceutics14050956","article-title":"Importance of spray\u2013wall interaction and post-deposition liquid motion in the transport and delivery of pharmaceutical nasal sprays","volume":"14","author":"Kolanjiyil","year":"2022","journal-title":"Pharmaceutics"},{"issue":"15","key":"10.1016\/j.ejpb.2026.115120_b0615","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1080\/00914037.2024.2443165","article-title":"Optimizing nasal drug delivery for peptides, proteins, and small molecules: strategic use of materials and techniques to target the CNS","volume":"74","author":"Mittal","year":"2025","journal-title":"International Journal of Polymeric Materials and Polymeric Biomaterials"},{"issue":"3","key":"10.1016\/j.ejpb.2026.115120_b0620","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3390\/pharmaceutics11030113","article-title":"Strategies to enhance drug absorption via nasal and pulmonary routes","volume":"11","author":"Ghadiri","year":"2019","journal-title":"Pharmaceutics"},{"issue":"8","key":"10.1016\/j.ejpb.2026.115120_b0625","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.3390\/molecules25081929","article-title":"Intranasal delivery of nanoformulations: A potential way of treatment for neurological disorders","volume":"25","author":"Islam","year":"2020","journal-title":"Molecules"},{"issue":"10","key":"10.1016\/j.ejpb.2026.115120_b0630","doi-asserted-by":"crossref","first-page":"663","DOI":"10.3390\/gels10100663","article-title":"Harmonizing innovations: an in-depth comparative review on the formulation, applications, and future perspectives of aerogels and hydrogels in pharmaceutical sciences","volume":"10","author":"Alaghawani","year":"2024","journal-title":"Gels"},{"issue":"42","key":"10.1016\/j.ejpb.2026.115120_b0635","doi-asserted-by":"crossref","first-page":"4279","DOI":"10.2174\/1381612827666210820100723","article-title":"A recent update on intranasal delivery of high molecular weight proteins, peptides, and hormones","volume":"27","author":"Sharma","year":"2021","journal-title":"Current Pharmaceutical Design"},{"key":"10.1016\/j.ejpb.2026.115120_b0640","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jconrel.2020.07.044","article-title":"V. Naidu, Stimuli-responsive In situ gelling system for nose-to-brain drug delivery","volume":"327","author":"Agrawal","year":"2020","journal-title":"Journal of Controlled Release"},{"issue":"3","key":"10.1016\/j.ejpb.2026.115120_b0645","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/nbt.3784","article-title":"Oligonucleotide therapies for disorders of the nervous system","volume":"35","author":"Khorkova","year":"2017","journal-title":"Nature Biotechnology"},{"issue":"27","key":"10.1016\/j.ejpb.2026.115120_b0650","doi-asserted-by":"crossref","first-page":"24335","DOI":"10.1021\/acsnano.5c03945","article-title":"Framework nucleic acid nanomaterials for central nervous system therapies: design for barrier penetration, targeted delivery, cellular uptake, and endosomal escape","volume":"19","author":"Chen","year":"2025","journal-title":"ACS Nano"},{"issue":"3","key":"10.1016\/j.ejpb.2026.115120_b0655","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/nbt.3779","article-title":"Cellular uptake and trafficking of antisense oligonucleotides","volume":"35","author":"Crooke","year":"2017","journal-title":"Nature Biotechnology"},{"issue":"19","key":"10.1016\/j.ejpb.2026.115120_b0660","first-page":"10357","volume":"25","author":"Lee","year":"2024","journal-title":"In vivo evaluation of nose-to-brain delivery of liposomal donepezil, memantine, and BACE-1 siRNA for Alzheimer\u2019s disease therapy, International Journal of Molecular Sciences"},{"key":"10.1016\/j.ejpb.2026.115120_b0665","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.974666","article-title":"Intranasal delivery: An attractive route for the administration of nucleic acid based therapeutics for CNS disorders","volume":"13","author":"Shah","year":"2022","journal-title":"Frontiers in Pharmacology"},{"issue":"16","key":"10.1016\/j.ejpb.2026.115120_b0670","doi-asserted-by":"crossref","first-page":"8564","DOI":"10.1021\/cr500131f","article-title":"Biodegradable polymer nanogels for drug\/nucleic acid delivery","volume":"115","author":"Li","year":"2015","journal-title":"Chemical Reviews"},{"issue":"7","key":"10.1016\/j.ejpb.2026.115120_b0675","doi-asserted-by":"crossref","first-page":"929","DOI":"10.3390\/pharmaceutics16070929","article-title":"Nasal drug delivery and nose-to-brain delivery technology development status and trend analysis: based on questionnaire survey and patent analysis","volume":"16","author":"Ge","year":"2024","journal-title":"Pharmaceutics"},{"issue":"13","key":"10.1016\/j.ejpb.2026.115120_b0680","doi-asserted-by":"crossref","first-page":"5022","DOI":"10.7150\/thno.98473","article-title":"Intranasal delivery of imaging agents to the brain","volume":"14","author":"Almahmoud","year":"2024","journal-title":"Theranostics"},{"key":"10.1016\/j.ejpb.2026.115120_b0685","doi-asserted-by":"crossref","first-page":"104156","DOI":"10.1016\/j.xphs.2026.104156","article-title":"Overcoming translational barriers in nose-to-brain drug delivery for clinical applications","author":"Zhang","year":"2026","journal-title":"Journal of Pharmaceutical Sciences"},{"issue":"12","key":"10.1016\/j.ejpb.2026.115120_b0690","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1080\/17425247.2025.2575944","article-title":"A fluid and particle mechanics perspective of nasal drug delivery","volume":"22","author":"Inthavong","year":"2025","journal-title":"Expert Opinion on Drug Delivery"},{"key":"10.1016\/j.ejpb.2026.115120_b0695","doi-asserted-by":"crossref","first-page":"124851","DOI":"10.1016\/j.ijpharm.2024.124851","article-title":"Characterization of anatomical variations of the nasal cavity in a subset of European patients and their impact on intranasal drug delivery","volume":"667","author":"Pasteur","year":"2024","journal-title":"International Journal of Pharmaceutics"},{"issue":"12","key":"10.1016\/j.ejpb.2026.115120_b0700","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1080\/17425247.2025.2568086","article-title":"Improving nasal spray deposition: advances and strategies to overcome anatomical and physiological barriers","volume":"22","author":"Seifelnasr","year":"2025","journal-title":"Expert Opinion on Drug Delivery"}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641126001414?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641126001414?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T02:25:45Z","timestamp":1783131945000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641126001414"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":140,"alternative-id":["S0939641126001414"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2026.115120","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hydrogels-based nasal sprays for nose-to-brain delivery: Formulation strategies, composite systems, and performance optimization","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2026.115120","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115120"}}